Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Año publicación: 2024

Subir documento: https://www.tandfonline.com/doi/full/10.1080/14656566.2024.2374463

Nombre investigadores: Tobias Puengel, Frank Tacke